NEW YORK, April 26 (GenomeWeb News) - After having previously put up heavy resistance to a hostile takeover bid by French drug maker Sanofi-Synthelabo, Aventis said yesterday that it is recommending its shareholders accept the deal in light of improved terms.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.